[Micronized fenofibrate and LDL-cholesterol subfractions].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Soska V;Soska V
  • Source:
    Vnitrni lekarstvi [Vnitr Lek] 1999 Jul; Vol. 45 (7), pp. 441-3.
  • Publication Type:
    English Abstract; Journal Article
  • Language:
    Czech
  • Additional Information
    • Transliterated Title:
      Mikronizovaný fenofibrát a subfrakce LDL-cholesterolu.
    • Source:
      Publisher: Ambit Media Country of Publication: Czech Republic NLM ID: 0413602 Publication Model: Print Cited Medium: Print ISSN: 0042-773X (Print) Linking ISSN: 0042773X NLM ISO Abbreviation: Vnitr Lek Subsets: MEDLINE
    • Publication Information:
      Publication: 2010- : Brno : Ambit Media
      Original Publication: 1973-<1994> : Praha : Avicenum
    • Subject Terms:
      Cardiovascular Diseases/*blood ; Cholesterol, LDL/*blood ; Fenofibrate/*therapeutic use ; Hyperlipidemias/*drug therapy ; Hypolipidemic Agents/*therapeutic use; Humans ; Hyperlipidemias/blood ; Risk Factors
    • Abstract:
      LDL-cholesterol subfractions have a different atherogenity; the most atherogenic are small LDL3 called small dense LDL. A clear relationship was proved between their concentration and early manifestation of ischaemic heart disease. In some instances they were found to act as an independent risk factor of cardiovascular disease. Their concentration depends to a great extent on the triacyglycerol concentration. They are found most frequently in patients with combined hyperlipidaemia, in associated metabolic syndrome and in patients with type 2 diabetes mellitus. Their plasma concentration can be reduced by non-pharmacological methods (restriction of animal fats, reduction of body weight, physical activity) as well as by pharmacological means (in particular fibrates). Micronized phenofibrate reduces significantly the concentration of small LDL3 and thus contributes to normalization of dyslipoproteinaemia and reduction of the risk of cardiovascular complications.
    • Accession Number:
      0 (Cholesterol, LDL)
      0 (Hypolipidemic Agents)
      U202363UOS (Fenofibrate)
    • Publication Date:
      Date Created: 20001025 Date Completed: 20001109 Latest Revision: 20131121
    • Publication Date:
      20250114
    • Accession Number:
      11045166